NavigationUser loginWho's onlineThere are currently 2 users and 97 guests online.
Online users |
Endo, Purdue end oxycontin patent disputeEndo, Purdue end oxycontin patent dispute http://www.topix.net/content/newscom/1514661619174084450508060976592264588835 August 28, 2006 Endo Pharmaceuticals said Monday it has settled its U.S. patent suit with Purdue Frederick over the pain drug OxyContin. Purdue's lawsuit had charged that Endo's oxycodone extended-release tablets in 10 mg, 20 mg, 40 mg and 80 mg strengths infringed Purdue's branded OxyContin product. Under the settlement deal, Endo will continue selling its generic product until Dec. 31 of this year and will be released from all liability for infringement in connection with Endo's prior and future sales of these products. The deal is subject to approval by the U.S. Federal Trade Commission and the Antitrust Division of the Department of Justice. Endo said it first launched its oxycodone extended-release drug on June 7, 2005, after a U.S. Court of Appeals for the Federal Circuit held Purdue's patents were unenforceable, but that decision was later remanded back to New York District court for further consideration. As a condition of the patent settlement, Purdue's lawsuit and Endo's counterclaims will be tossed out, Endo said. We are pleased to have reached a resolution of our dispute with Purdue that relieves us of the risk of patent infringement liability for selling our oxycodone extended-release products, and allows us to continue selling the products for a period of time, said Caroline Manogue, Edno's executive vice president and chief legal officer. Further, with the lawsuit behind us, we can better focus on the current launch of Opana and Opana ER, Endo's recently approved oxymorphone immediate- and extended-release products. Copyright 2006 by United Press International Does this mean that endo has to stop selling its generic oxycontin by December 2006?( categories: Discussion of Prescription and OTC Meds )
from my reading or
from my reading or understanding of "Under the settlement deal, Endo will continue selling its generic product until Dec. 31 of this year and will be released from all liability for infringement in connection with Endo's prior and future sales of these products. " it is saying that Purdue will drop its suit against endo pharms. in other words i believe that they (Endo) will continue making sus release oxycodone. i do see where the confusion is.... it almost looks like it means that in Dec 06 they will stop. i believe that we might be misinterpreting this and it is just a sort of "legalmubojumbo":) all thoughts and opinions expressed are those of my own and should not be mistaken for medical advice. i am not a doctor nor a pharmacist. all medical questions should be answered by a licensed pharmacist, doctor, or primary care manager. Thanks for clearing that up
Thanks for clearing that up phisher, I knew one of our top poster would clarify my confusion.
My comments are my opinions based on the questions posted on this message board and should be taken purely as is and not as medical gospal. Please consult medical concerns with medical proffesionals. Thank You! Confusion!!!!
Phisher, Reread these parts... 1) Under the settlement deal, Endo will continue selling its generic product until Dec. 31 of this year. "We are pleased to have reached a resolution of our dispute with Purdue that relieves us of the risk of patent infringement liability for selling our oxycodone extended-release products, and allows us to continue selling the products for a period of time, said Caroline Manogue, Edno's executive vice president and chief legal officer. " THen it goes on to say: " Further, with the lawsuit behind us, we can better focus on the current launch of Opana and Opana ER, Endo's recently approved oxymorphone immediate- and extended-release products. " So, it looks to me like they WILL be ending the sale of the Oxy because they are gearing up to sell the Opana instead. They mentioned future because from tomorrow until Dec 31 (in this reference) it is future sales. good point.you are probably
good point. you are probably correct. i was confused b/c the wording but what you said does make sense and i am assuming that your right. if i get a chance i will try to call endo today and see if i can get a straight and simple answer. i wonder if the others will quit making it also? all thoughts and opinions expressed are those of my own and should not be mistaken for medical advice. i am not a doctor nor a pharmacist. all medical questions should be answered by a licensed pharmacist, doctor, or primary care manager. Oxycodone ER Patent Dispute
Phisher, I think all the companies that make generic OxyContin will stop marketing the pills. It's possible the 'authorized' generics (the ABG pills) will continue to be distributed. Excerpt of Press Release from Teva Pharmaceuticals:
Quote: Teva Announces Settlement Of Oxycontin® Litigation Jerusalem, Israel, August 29, 2006 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that it has signed an agreement with The Purdue Frederick Company and certain of its affiliates to settle patent infringement litigation pertaining to Teva's generic version of Purdue's OxyContin® (oxycodone HCl extended-release) Tablets pending in the United States District Court for the Southern District of New York. The agreement, which involves a full release of Teva, as well as its distributors, purchasers, and patients, and which calls for Teva to cease selling its oxycodone products at a future date upon certain contingencies, will be submitted to the U.S. Federal Trade Commission ("FTC") and the Antitrust Division of the Department of Justice as required by law. Except as described, the terms of the settlement are confidential and are subject to a review by the above federal agencies and the approval of the District Court.
So now is the time to save all those generic OxyContin images on your hard drive for future oxycodone ER pill ID questions that will surely appear!
I'm not a pharmacist or a medical doctor. This message is not medical advice nor is it an offer to provide medical advice. All drug identifications should be validated by a licensed MD or pharmacist. well... i hope i dont catch
well... i hope i dont catch to much flame for this statement but i have to say that i am glad that this is happening. in my OPINION all the other makers or at least the ones i have tried seemed inferior to the originals. many of the generics just seemed as if they were made "cheap" and also didnt seem to last as long in my opinion. usually i am all for generic drugs and honestly believe that in most cases they are as good as the brand. however i had always felt like this was an excpetion. it is also good in my opinion b/c now that there wont be any or at least as many generics insurance will cover it accordingly. i was VERY shocked when the first generics cam out last summer at the still very high prices. if i remember correctly before insurance paid, 60 cnt 40mg were about 250 at CVS and 60 cnt 40mg of the endos were about 210. the savings was NOT worth it in my opinion. however since the generics were available at that time insurance that i had did not want to cover any of the costs for the brand (since generic was available). any way after a long drawn out fight w/ the insurance co i finally got them to cover the cost of the brand since the doctor would specifically write "dispense as written" on the rx form. any way whether i was right or wrong for it i harbored allot of ill will towards the generic. sorry for the rant i just wanted to voice a strong opinion on the subject. all thoughts and opinions expressed are those of my own and should not be mistaken for medical advice. i am not a doctor nor a pharmacist. all medical questions should be answered by a licensed pharmacist, doctor, or primary care manager. I guess we could have gone
I guess we could have gone straight to the source of the lawsuits to get a clear answer.
From Purdue regarding Endo: "According to the agreement, Endo will stop selling infringing versions of OxyContin by the end of 2006. In exchange, Purdue Pharma will not pursue damages against Endo for Endo's past infringement of its OxyContin patents."
From Purdue regarding Teva: "Teva will cease selling its infringing oxycodone products at a future date and Purdue Pharma will not pursue damages against Teva for past infringement." The article goes on to say; "We are pleased that Teva will respect our invention of an important medicine. I believe we would have prevailed in our lawsuit and the court eventually would have ordered Teva to stop selling its infringing product."
Kirby had it nailed as usual. bumped it up:)all thoughts
bumped it up:) all thoughts and opinions expressed are those of my own and should not be mistaken for medical advice. i am not a doctor nor a pharmacist. all medical questions should be answered by a licensed pharmacist, doctor, or primary care manager. your missing one important thing...
Endo is releasing oxymorphone...........was never easy to get for drug abuse and only given for severe severe pain and only in suppository<sp> or injection... if endo releases oxymorphone, lets say in a pill form, it will out do oxycodone in the medical and street market It is more addictive than oxycontin, kinda hops over oxycodone. You'll see what I mean if it does happen that way........
*I am not a doctor* Quote:if endo releases
Quote: if endo releases oxymorphone, lets say in a pill form, it will out do oxycodone in the medical and street market
Umm, they did release it in pill form. It comes in an instant and extended release formulation. We have several posts that discuss the drug and some photos.
Opana ER 10mg (extended release Oxymorphone)
Oxycontin ER
I am confused!!! I just got switched from methadone to oxycontin so my question is this.... After Dec 31 can I still get the generic? If not will insurance cover the brand? Please respond still going through some withdrawls changing over so if you could make it really simple for me I would greatly appreciate it. Thank you so much. Jamie it completely depends on
it completely depends on your individual insurance. i can tell you that if you have BCBS they will cover it although your co-pay may go up. all thoughts and opinions expressed are those of my own and should not be mistaken for medical advice. i am not a doctor nor a pharmacist. all medical questions should be answered by a licensed pharmacist, doctor, or primary care manager. Understatement of the year
Understatement of the year nominee... I understand that oxymorphone is a tad bit more potent than oxycodone ... Quahog, man when you understate, you REALLY understate. LOL I show that Oxymorphone is a bit over 3 times as potent as oxycodone. That kind of like saying a Yugo is a tad bit slower than a corvette in the 1/4 mile. Comparison
Traveler ~ you can go to this post to see the comparison chart. I think it will answer any questions that you may have on what is stronger and how it compares to other opiates. http://www.pharmer.org/node/3757
Danielle I See you found the hidden
I See you found the hidden humor in my post Rawoody But seriously, I find the potency issue on some medications to be over rated.What may work great on someone may not work at all on someone else. There are many factors such as how the drug is released and absorbed by the human body. and after speaking with a few physicians on this issue it is apparent that they don't like to go by the potency rate either. corrected
I didnt know Opana was released already(not looking into new drugs -ex addict) . I guess its oral bio is somewhat weak. It is proven to be more addictive than oxycodone but I havent heard any comparison from oxycodone for pain patients as far as what works better taken as directed.
*Im am not a doctor, cant you tell?* (edited by TeamPharmer) |
Joined: 2006-03-21